Hypertrophic Cardiomyopathy (HCM): A promising new treatment (Mavacamten / Cardiac Myosin Inhibitors)
HCM ( Hypertrophic Cardiomyopathy ) is a disease caused by mutations in your genes which control the structure of your heart muscle proteins. It causes abnormal growth of these cells, thickening the walls of the heart. When these walls thicken, the functioning of your heart can be impaired due to the change in its structure. Depending on case to case, some people can develop obstruction to blood flow from their left ventricle, and some may experience diastolic dysfunction (when your heart cannot relax properly when it has to be filled with blood to pump out) resulting in a range of uncomfortable and painful symptoms. These symptoms include chest pain, shortness of breath, fatigue, and a higher risk of arrhythmias. A targeted cardiac myosin inhibitor , like Mavacamten , is a new medication which has been developed to treat HCM. It works by specifically degenerating the myosin protein in your heart muscles (the protein involved in contraction of your heart muscles). When people have H...